Naropin (ropivacaine hydrochloride Injection, USP), 0.5%, 100 mg per 20 mL (5 mg per mL), Twenty-five, 20 mL Single-Dose Vials, Rx only, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-286-23; NDC Vial: 63323-286-05
Drug Recall
Official source record
- Recall number
- D-0727-2026
- Event ID
- 99449
- Classification
- Class II
- Status
- Ongoing
- Recalling company
- Fresenius Kabi USA, LLC
- Reason for recall
- Presence of Particulate Matter: Hair was found in products
- Report date
- July 29, 2026
- Recall initiation date
- July 16, 2026
- Termination date
- Not terminated as of this source record
- Distribution pattern
- Nationwide within in the USA
Drug product identifiers
- Manufacturer
- Fresenius Kabi USA, LLC
- Brand name
- NAROPIN
- Generic name
- ROPIVACAINE HYDROCHLORIDE
- Substance name
- ROPIVACAINE HYDROCHLORIDE
- Product NDCs
- 63323-285; 63323-286; 63323-287; 63323-288
- Package NDCs
- 63323-285-01; 63323-285-02; 63323-285-03; 63323-285-04; 63323-285-06; 63323-285-07; 63323-285-10; 63323-285-13; 63323-285-20; 63323-285-23; 63323-285-51; 63323-285-57; 63323-285-61; 63323-285-63; 63323-285-64; 63323-285-65; 63323-286-00; 63323-286-01; 63323-286-03; 63323-286-05; 63323-286-09; 63323-286-11; 63323-286-20; 63323-286-23; 63323-286-30; 63323-286-31; 63323-286-33; 63323-286-35; 63323-286-63; 63323-287-01; 63323-287-03; 63323-287-20; 63323-287-21; 63323-288-01; 63323-288-03; 63323-288-06; 63323-288-07; 63323-288-10; 63323-288-11; 63323-288-20; 63323-288-21
- Routes
- EPIDURAL; INFILTRATION
Where this information comes from
View FDA enforcement record -- the specific openFDA drug enforcement record this summary was built from.
FDA Enforcement Reports -- FDA's general, official recall and enforcement information.
Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for details.
Retrieved by Public Health Trace:
Frequently asked questions
What does a Class II mean?
A situation in which use of or exposure to a product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote.
Is this recall still active?
According to the FDA, this recall's status is "Ongoing." Always confirm the current status using the source links below, since status can change after Public Health Trace last retrieved this record.
What should I do if I have this medication?
Do not start, stop, or change any medication based on this page. Follow the instructions published by the FDA and the recalling company (see the source links below), and talk to your pharmacist or physician if you have questions about a specific medication.
Where can I find more official information?
The source links below, published by the FDA, are the authoritative record for this recall, including any updates issued after this summary was retrieved.
Public Health Trace republishes official FDA drug recall information -- it is not affiliated with the FDA, does not verify or supplement what the source has published, and does not provide medical advice. Never start, stop, or change a medication based on this page. Always follow the guidance of your pharmacist or physician, and consult the official source links above for the most current information. Read the full medical disclaimer.
